+44(0) 800 772 3004

Daewoong Pharmeceuticals Signs $25US million contract Iraq and Jordan to Provide 6 different medicines

Has Already begun trading and establishing their presence in the middle east in 2015

Iraq and Jordan have recently signed a $25US million contract with South Korea’s Daewoong Pharmaceutical to supply six different types of drugs: 
Ursa, for liver function improvement; Orlostar, for high blood pressure and hyperlipidemia; Easyef for diabetic foot ulcer; Daewoong pitavastatin calcium tab, for hyperlipidemia;antibiotic Gomcephin; and vitamin supplement Roman C powder. The South Korean company recently entered the middle eastern market in 2015. 


Read more news like this

Other Industry News